GSK plc (LON:GSK)
2,144.00
+37.00 (1.76%)
Apr 2, 2026, 7:13 PM GMT
GSK plc Revenue
In the year 2025, GSK plc had annual revenue of 32.67B GBP with 4.11% growth. GSK plc had revenue of 8.62B in the quarter ending December 31, 2025, with 6.17% growth.
Revenue
32.67B
Revenue Growth
+4.11%
P/S Ratio
2.62
Revenue / Employee
488.73K
Employees
66,841
Market Cap
85.69B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 32.67B | 1.29B | 4.11% |
| Dec 31, 2024 | 31.38B | 1.05B | 3.46% |
| Dec 31, 2023 | 30.33B | 1.00B | 3.42% |
| Dec 31, 2022 | 29.32B | 4.63B | 18.74% |
| Dec 31, 2021 | 24.70B | 342.00M | 1.40% |
| Dec 31, 2020 | 24.35B | -9.40B | -27.85% |
| Dec 31, 2019 | 33.75B | 2.93B | 9.52% |
| Dec 31, 2018 | 30.82B | 635.00M | 2.10% |
| Dec 31, 2017 | 30.19B | 2.30B | 8.24% |
| Dec 31, 2016 | 27.89B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.64B |
| Haleon | 11.03B |
| Smith & Nephew | 4.58B |
| Hikma Pharmaceuticals | 2.49B |
| Convatec Group | 1.81B |
| CVS Group | 692.80M |
| Genus | 672.00M |
| HUTCHMED (China) | 407.54M |
GSK plc News
- 2 days ago - GSK Announces Completion Of Pfizer's Exit Of Its Investment In ViiV Healthcare - Nasdaq
- 3 days ago - Samsung Biologics completes acquisition of GSK's manufacturing facility in Rockville, Maryland - PRNewsWire
- 3 days ago - GSK Achieves Approval in China for Asthma Treatment Exdensur - GuruFocus
- 3 days ago - GSK (GSK) Seeks Chinese Approval for New Hepatitis B Treatment - GuruFocus
- 4 days ago - Pharma Offers Defensive Plays in an Uncertain Market. Charts Say Buy These 2 Stocks. - Barrons
- 4 days ago - GSK Announces Approval For Exdensur In China - Nasdaq
- 7 days ago - GSK: European Medicines Agency To Review MAA For Bepirovirsen - Nasdaq
- 8 days ago - GSK plc (GSK) Presents at Goldman Sachs 9th Annual Biopharma Innovation Summit Transcript - Seeking Alpha